Cargando…
Hydroxychloroquine in nephrology: current status and future directions
Hydroxychloroquine is one of the oldest disease-modifying anti-rheumatic drugs in clinical use. The drug interferes with lysosomal activity and antigen presentation, inhibits autophagy, and decreases transcription of pro-inflammatory cytokines. Owing to its immunomodulatory, anti-inflammatory, anti-...
Autores principales: | Rao, Indu Ramachandra, Kolakemar, Ashwija, Shenoy, Srinivas Vinayak, Prabhu, Ravindra Attur, Nagaraju, Shankar Prasad, Rangaswamy, Dharshan, Bhojaraja, Mohan Varadanayakanahalli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638202/ https://www.ncbi.nlm.nih.gov/pubmed/37530940 http://dx.doi.org/10.1007/s40620-023-01733-6 |
Ejemplares similares
-
Measurement of Blood Pressure in Chronic Kidney Disease: Time to Change Our Clinical Practice - A Comprehensive Review
por: Nagaraju, Shankar Prasad, et al.
Publicado: (2022) -
Hyponatremia in Melioidosis: Analysis of 10-year Data from a Hospital-Based Registry
por: Rao, Indu Ramachandra, et al.
Publicado: (2022) -
Risk Factors of Pulmonary Hypertension in Patients on Hemodialysis: A Single Center Study
por: Nagaraju, Shankar Prasad, et al.
Publicado: (2021) -
Novel biomarkers for prognosticating diabetic kidney disease progression
por: Swaminathan, Shilna Muttickal, et al.
Publicado: (2022) -
Uremic pruritus: prevalence, determinants, and its impact on health-related quality of life and sleep in Indian patients undergoing hemodialysis
por: Shetty, Deeksha, et al.
Publicado: (2023)